Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BMS describes angiotensin II antagonists

May 20, 1997

Ribi ImmunoChem offers licenses for cardioprotectant

May 19, 1997

Antiproliferative effects of PCA-4230 in vascular smooth muscle cells

May 16, 1997

SmithKline Beechan to market Kissei's tranilast

May 15, 1997

Antiischemic potassium channel activators described by BMS

May 15, 1997

Selective alpha1b-adrenoceptor blockers from Merck & Co.

May 14, 1997

ET antagonists described by Ciba-Geigy Japan (Novartis)

May 12, 1997

FDA approves Mylan's generic extended-release diltiazem

May 9, 1997

Mibefradil evaluated for impact on mortality in large CHF trial

May 8, 1997

ANDA filed for Biovail generic calcium channel blocker

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...